Cultures of avicin treated myeloma cells showed a decrease in the levels of IL-6, a major inducer of Stat3 activity, which is also known to be under the transcriptional regulation of Stat3 [21], [22]. This evidence concerns the gene STAT3 and plasma cell myeloma.